Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2013

View Archived Issues

Abcodia licenses algorithm for the diagnosis of ovarian cancer

AstraZeneca reports on discovery of a novel DNA gyrase inhibitor: NBTI-5463

Small-molecule mediated activation of cell signaling to increase hematopoietic stem cell expansion

Retrophin makes new proposal to acquire Transcept

EpimiRNA Consortium receives funding to study microRNA therapeutics in epilepsy

Study of CPX-351 in pediatric and young adults commences

Researchers test H7N9 avian influenza vaccine candidate

Carboxy-terminal fragment of CPE shows potential in imaging treatment-resistant ovarian cancer

Kineret receives positive CHMP opinion for cryopyrin-associated periodic syndromes

Isis Pharmaceuticals reports phase II ISIS-APOCIIIRx data in familial chylomicronemia

Dual bronchodilator Ultibro inhalation capsules approved in Europe for COPD

Stelara obtains FDA approval for active psoriatic arthritis

A local inhibitor of ROCK prevents corneal scarring and neovascularization in vivo

Takeda obtains European approval for three new type 2 diabetes therapies

First patient treated with NTCell regenerative cell therapy for Parkinson's disease

NIH funding boosts new Alzheimer's disease research

EC approves Revolade in chronic hepatitis C-associated thrombocytopenia

CHMP issues positive opinion for PSD-502 in premature ejaculation

BioMarin begins dosing in phase I/II trial of enzyme replacement therapy for Batten disease

FDA issues complete response letter for sugammadex

EMA committee recommends approval of Cimzia in new indication

Researchers in Russia patent novel antifungal agents

Nampt inhibitors jointly reported by FORMA Therapeutics and Genentech

Northwestern University divulges agents for S. pneumoniae infections

Boehringer Ingelheim and Vitae Pharmaceuticals patent BACE1 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...